ANIK
ANIK
US0352551081
Anika Therapeutics Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 112.819.000 119.907.000
5.9%
Cost of Revenue 49.012.000 43.909.000
11.6%
Gross Profit 63.807.000 75.998.000
16.0%
74.858.000 81.099.000
7.7%
Operating Income -11.051.000 -5.101.000
116.6%
Pretax Income -9.307.000 -2.764.000
236.7%
Net Income Common Stockholders -10.880.000 -56.385.000
80.7%
-- --
--
-- --
--
ende